UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 2 |
Linde
LIN
|
+$786M |
| 3 |
Energy Transfer Partners
ET
|
+$666M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$445M |
| 5 |
UBS Group
UBS
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.06B |
| 2 |
Colgate-Palmolive
CL
|
+$665M |
| 3 |
PX
Praxair Inc
PX
|
+$528M |
| 4 |
Apple
AAPL
|
+$503M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.03% |
| 2 | Financials | 6.64% |
| 3 | Healthcare | 6.26% |
| 4 | Consumer Discretionary | 5.11% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CACG
1951
DELISTED
Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF
CACG
| $6.3M | ﹤0.01% |
235,883
-10,297
| -4% | -$298K |
|
|
BSCO
1952
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $6.3M | ﹤0.01% |
315,508
+3,960
| +1% | +$78.8K |
|
1953
Ligand Pharmaceuticals
LGND
$6.03B
| $6.3M | ﹤0.01% |
74,392
+12,697
| +21% | +$1.35M |
|
|
OPP
1954
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$190M
| $6.29M | ﹤0.01% |
391,847
-12,795
| -3% | -$205K |
|
1955
Alexandria Real Estate Equities
ARE
$8.52B
| $6.29M | ﹤0.01% |
54,559
-35,920
| -40% | -$4.38M |
|
1956
CALL
VanEck Junior Gold Miners ETF
GDXJ
$7.33B
| $6.29M | ﹤0.01% |
208,000
-159,700
| -43% | -$4.49M |
|
|
WPX
1957
CALL
DELISTED
WPX Energy, Inc.
WPX
| $6.27M | ﹤0.01% |
552,500
+175,700
| +47% | +$2.66M |
|
1958
Marcus & Millichap
MMI
$1.17B
| $6.27M | ﹤0.01% |
182,546
+13,343
| +8% | +$457K |
|
1959
Global Payments
GPN
$24.1B
| $6.25M | ﹤0.01% |
60,577
-50,569
| -45% | -$5.57M |
|
1960
Iron Mountain
IRM
$37.3B
| $6.24M | ﹤0.01% |
192,393
-123,437
| -39% | -$4.05M |
|
1961
Korea Electric Power
KEP
$15.8B
| $6.23M | ﹤0.01% |
422,365
-285,150
| -40% | -$3.64M |
|
1962
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
| $6.23M | ﹤0.01% |
442,291
+10,150
| +2% | +$157K |
|
1963
PUT
Intuitive Surgical
ISRG
$130B
| $6.23M | ﹤0.01% |
39,000
-1,200
| -3% | -$203K |
|
|
FOMX
1964
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $6.22M | ﹤0.01% |
1,732,997
+1,725,874
| +24,230% | +$7.51M |
|
1965
PUT
Yelp
YELP
$1.46B
| $6.22M | ﹤0.01% |
177,800
| – | – |
|
1966
Loews
L
$23.7B
| $6.22M | ﹤0.01% |
136,536
-64,742
| -32% | -$3.05M |
|
|
CDK
1967
DELISTED
CDK Global, Inc.
CDK
| $6.21M | ﹤0.01% |
129,633
-33,744
| -21% | -$1.78M |
|
|
CLVS
1968
DELISTED
Clovis Oncology, Inc.
CLVS
| $6.2M | ﹤0.01% |
345,041
+313,376
| +990% | +$6.4M |
|
1969
NewtekOne
NEWT
$445M
| $6.2M | ﹤0.01% |
355,222
-24,819
| -7% | -$479K |
|
1970
Invesco CEF Income Composite ETF
PCEF
$812M
| $6.19M | ﹤0.01% |
305,932
+134,057
| +78% | +$2.86M |
|
1971
Mitek Systems
MITK
$800M
| $6.18M | ﹤0.01% |
572,011
-123,544
| -18% | -$1.12M |
|
1972
John Wiley & Sons Class A
WLY
$2.78B
| $6.18M | ﹤0.01% |
131,618
+85,825
| +187% | +$4.62M |
|
1973
Olin
OLN
$2.17B
| $6.16M | ﹤0.01% |
306,225
+61,391
| +25% | +$1.31M |
|
1974
Molson Coors Class B
TAP
$7.93B
| $6.15M | ﹤0.01% |
109,557
+25,059
| +30% | +$1.54M |
|
|
CONE
1975
DELISTED
CyrusOne Inc Common Stock
CONE
| $6.15M | ﹤0.01% |
116,316
+46,230
| +66% | +$2.64M |
|
Similar funds
UBS Group's Q4 2018 Portfolio in Review
As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
- UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
- UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
- UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
- UBS Group opened 731 new positions and closed 648 in Q4 2018.
- UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.
Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.